Premium
Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
Author(s) -
Mimpen Max,
Muris AnneHilde,
Rolf Linda,
Gerlach Oliver,
Kuhle Jens,
Hupperts Raymond,
Smolders Joost,
Damoiseaux Jan
Publication year - 2021
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.14680
Subject(s) - multiple sclerosis , medicine , biomarker , flow cytometry , peripheral blood mononuclear cell , cell , immunology , biology , in vitro , biochemistry
Background and purpose Natural killer (NK) cells may play a role in multiple sclerosis (MS). Ratios of NK cells to CD4 + T cells have been proposed as a biomarker for the therapeutic effect of stem cell transplantation in MS. The objectives here were to explore the relevance of this ratio in MS patients by analysing NK and T cell subsets, as well as their prognostic value for disease activity. Methods Baseline peripheral blood mononuclear cells of 50 relapsing–remitting MS patients, participating in our vitamin D supplementation study (SOLARIUM), were analysed with flow cytometry. Disease activity was measured as new magnetic resonance imaging lesions, relapses and mean plasma neurofilament light chain levels after 48 weeks of follow‐up. Results The proportion of NK cells correlated negatively with CD4 + T cells ( R = −0.335, p = 0.001) and interleukin 17A (IL‐17A + ) CD4 + T cells ( R = −0.203, p = 0.043). Participants with magnetic resonance imaging activity or relapses displayed lower NK/IL‐17A + CD4 + T cell ratios ( p =0.025 and p = 0.006, respectively). The NK/IL‐17A + CD4 + T cell ratio correlated negatively with neurofilament light chain levels ( R = −0.320, p = 0.050). Vitamin D supplementation did not affect these ratios. Conclusions Our data suggest a protective role of an expanded NK cell compartment compared to the CD4 + T cell subset fractions in relapsing–remitting MS patients. NK/CD4 + T cell ratios may be a prognostic biomarker for disease activity in MS.